BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 5.10.2007

New Animal Drugs; Ractopamine

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Elanco Animal Health. The supplemental NADA provides for an increased level of monensin in four-way combination Type C medicated feeds containing ractopamine, melengestrol, monensin, and tylosin for heifers fed in confinement for slaughter, a revision to bacterial pathogen nomenclature, and an increase in liver tolerance.

Source: Federal Register — Food and Drug AdministrationOpen original release →